Gold-Nanostar-Chitosan-Mediated Delivery of SARS-CoV-2 DNA Vaccine for Respiratory Mucosal Immunization: Development and Proof-of-Principle.

Kumar, Uday S; Afjei, Rayhaneh; Ferrara, Katherine; Massoud, Tarik F; Paulmurugan, Ramasamy

Kumar, Uday S; Afjei, Rayhaneh; Ferrara, Katherine; Massoud, Tarik F; Paulmurugan, Ramasamy.

Afiliación

Kumar US; Molecular Imaging Program at Stanford (MIPS), Department of Radiology, Stanford University School of Medicine, Stanford, California 94305, United States.
Afjei R; Molecular Imaging Program at Stanford (MIPS), Department of Radiology, Stanford University School of Medicine, Stanford, California 94305, United States.
Ferrara K; Molecular Imaging Program at Stanford (MIPS), Department of Radiology, Stanford University School of Medicine, Stanford, California 94305, United States.
Massoud TF; Molecular Imaging Program at Stanford (MIPS), Department of Radiology, Stanford University School of Medicine, Stanford, California 94305, United States.
Paulmurugan R; Molecular Imaging Program at Stanford (MIPS), Department of Radiology, Stanford University School of Medicine, Stanford, California 94305, United States.

ACS Nano ; 15(11): 17582-17601, 2021 Nov 23.

Article en En | MEDLINE | ID: mdl-34705425

Asunto(s)

COVID-19; Quitosano; Vacunas de ADN; Vacunas Virales; Ratones; Animales; Humanos; Vacunas contra la COVID-19; Pandemias; SARS-CoV-2; Anticuerpos Antivirales; Oro; COVID-19/prevención & control; Ratones Endogámicos C57BL; Anticuerpos Neutralizantes; Inmunización; Ratones Endogámicos BALB C; Inmunoglobulina A

Palabras clave

COVID-19; DNA vaccine; SARS-CoV-2; chitosan; gold nanoparticles; intranasal delivery; mRNA vaccine

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Vacunas Virales / Vacunas de ADN / Quitosano / COVID-19 Idioma: En Revista: ACS Nano Año: 2021 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google